Clinical Trials Directory

Trials / Completed

CompletedNCT04525261

Natural History of Patients With Inherited Retinal Diseases Due to Mutations in RPE65 Gene

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
University of Campania Luigi Vanvitelli · Academic / Other
Sex
All
Age
3 Years
Healthy volunteers
Not accepted

Summary

Rationale: In preparation for treatment with gene therapy, this study is being conducted in order to investigate the natural history of Inherited Retinal Dystrophies (IRDs) due to mutations in RPE65 gene. Such a study will help identify suitable patients for therapeutic intervention. Methodology: This is a multicenter retrospective, descriptive chart review study designed to assess retinal structure and function in subjects with IRDs due to mutation in RPE65 gene by visual acuity, visual field measurements, Optical Coherence Tomography (OCT), and a number of other vision-related assessments.

Conditions

Timeline

Start date
2020-05-01
Primary completion
2020-07-31
Completion
2020-07-31
First posted
2020-08-25
Last updated
2023-11-29

Locations

9 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT04525261. Inclusion in this directory is not an endorsement.

Natural History of Patients With Inherited Retinal Diseases Due to Mutations in RPE65 Gene (NCT04525261) · Clinical Trials Directory